日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella.

具有多表位融合的FcRn驱动纳米工程粘膜疫苗可诱导强大的双重免疫力,并对布鲁氏菌提供长期保护

Tian Tingting, Zhu Yuejie, Shang Kaiyu, Shi Huidong, Xu Ruixue, Li Mingzhe, Pu Fuling, Kuang Junyu, Ding Jianbing, Zhang Fengbo

Development and evaluation of novel Brucella diagnostic antigen protein ST

新型布鲁氏菌诊断抗原蛋白ST的开发和评估

Shi, Juan; Tian, Tingting; Qi, Xinxin; Shi, Huidong; Shang, Kaiyu; Yin, Zhengwei; Ding, Jianbing; Xu, Ruixue; Pu, Fuling; Li, Mingzhe; Kuang, Junyu; Zhu, Yuejie; Zhang, Fengbo

Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches

利用免疫信息学方法设计靶向布鲁氏菌OMP31、LptE和VirB2的多表位重组卡介苗

Li, Chuang; Zhu, Yuejie; Qi, Xingxing; Chai, Zhenglong; Luo, Jiarui; Shang, Kaiyu; Tian, Tingting; Shi, Huidong; Li, Mingzhe; Xu, Ruixue; Pu, Fuling; Kuang, Junyu; Zhang, Fengbo